|
Volumn 23, Issue 10, 2008, Pages 3050-3052
|
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: Should we CARE-2 avoid them?
|
Author keywords
Calcification; Calcium acetate; Dialysis; Phosphate binder; Sevelamer
|
Indexed keywords
ATORVASTATIN;
CALCIUM ACETATE;
CALCIUM CARBONATE;
PARATHYROID HORMONE;
PHOSPHATE;
SEVELAMER;
VITAMIN D;
BLOOD VESSEL CALCIFICATION;
CALCIUM INTAKE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DIALYSIS;
DRUG BINDING;
HEMODIALYSIS;
HUMAN;
HYPERCALCEMIA;
PATIENT CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SCORING SYSTEM;
SHORT SURVEY;
ACETATES;
CALCINOSIS;
CALCIUM;
CALCIUM CARBONATE;
CALCIUM COMPOUNDS;
CARDIOVASCULAR DISEASES;
CHELATING AGENTS;
HUMANS;
PHOSPHATES;
POLYAMINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RENAL DIALYSIS;
|
EID: 52449091565
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfn393 Document Type: Short Survey |
Times cited : (29)
|
References (9)
|